Physical Activity Directly Before Immunotherapy (Nivolumab and Ipilimumab) in Melanoma
- Status
- RECRUITING
- Phase
- NA
Clinical Trials Related to Metastatic Melanoma
Related studies linked through entity extraction aliases.
ctDNA-guided Addition of Ipilimumab to Patients Receiving Nivolumab and Relatlimab
- Status
- RECRUITING
- Phase
- PHASE4
A Study To Assess the Safety, and Tolerability of Nivolumab + Relatlimab Fixed-Dose Combination (FDC) In Untreated, Unresectable or Metastatic Melanoma Participants In India
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE4
IFN-Gamma Expression as a Predictor of Response to Immune Checkpoint Inhibitors in First-Line Metastatic Melanoma
- Status
- COMPLETED
- Phase
- NA
Immunotherapy Efficacy and PD-L1 as a Predictive Biomarker in Metastatic Melanoma in Slovenia
- Status
- RECRUITING
- Phase
- NA
Efficacy of First-Line Immunotherapy in Metastatic Melanoma in Slovenia and Identification of Predictive Biomarkers
- Status
- RECRUITING
- Phase
- NA
Morning Versus Afternoon Administration of Immunotherapy for the Treatment of Advanced or Metastatic Solid Tumors, The Knight SHIFT Study
- Status
- RECRUITING
- Phase
- PHASE4
A Study of Lifileucel (Tumor-infiltrating Lymphocytes) in Adults With Advanced Melanoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Hepzato Kit and Opdualag for Metastatic Melanoma and Liver Metastasis
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
IL-17 Blockade to Decrease irAEs (REPLAY)
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
Mirdametinib in Patients With Advanced NF1-mutant Melanoma
- Status
- RECRUITING
- Phase
- PHASE2
Consolidative Use of Radiotherapy to Block Oligoprogression in Patients With Metastatic Melanoma
- Status
- RECRUITING
- Phase
- NA
A Study to Evaluate Adze1.C in Participants With Metastatic Melanoma
- Status
- RECRUITING
- Phase
- PHASE1
TNFα and IL-2 Coding Oncolytic Adenovirus TILT-123 With Lymphocyte-depleting Chemotherapy and TILs in the Treatment of Melanoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
A Study to Investigate the Safety and Efficacy of IOV-3001 in Adults With Advanced Melanoma Who Will Receive Lifileucel
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Study to Assess the Long-term Safety Outcomes in Patients Previously Treated With RP1, RP2, or RP3
- Status
- RECRUITING
- Phase
- N/A
A Study to Learn About the Study Medicine Called PF-08046031 in Advanced Melanoma and Other Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
Power of Liquid Biopsy Tracking in Immunotherapy Treated Stage IV Melanoma
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
STIL101 for Injection for the Treatment of Locally Advanced, Metastatic or Unresectable Pancreatic Cancer, Colorectal Cancer, Renal Cell Cancer, Cervical Cancer and Melanoma
- Status
- WITHDRAWN
- Phase
- PHASE1
Treatment of Metastatic Melanoma with Lenvatinib + Anti-PD1
- Status
- COMPLETED
- Phase
- N/A